Search results

1973 results

Sorted by Date . Sort by Relevance

  1. The committee noted that there was no clinical evidence showing that having patiromer improved length or quality of life or allowed patients to stay on optimal doses of renin-angiotensin-aldosterone system (RAAS) inhibitors. It therefore considered that it would be valuable to have studies comparing patiromer plus standard care with standard care alone in people with confirmed hyperkalaemia of 6.0 mmol/litre and above, and that these should investigate: - mortality- disease progression- patterns of RAAS inhibitor use- healthcare utilisation and- health-related quality of life. The committee recalled that the DIAMOND trial is ongoing and may help to provide evidence on mortality (see section 3.11). However, the trial is not going to complete until 2022. The committee concluded that the guidance should be reviewed when evidence from DIAMOND is available.

    Recommendation ID TA623/1 Question The committee noted that there was no clinical evidence showing that having patiromer improved length

  2. The percentage of patients with diabetes who have had the following care processes performed in the preceding 12 months: BMI measurement; BP measurement; HbA1c measurement; Cholesterol measurement; Record of smoking status; Foot examination; Albumin: creatinine ratio; Serum creatinine measurement

    The percentage of patients with diabetes who have had the following care processes performed in the preceding 12 months: BMI measurement; BP...

  3. Hearing loss

    Everything NICE has said on hearing loss or impairment in adults in an interactive flowchart

  4. Ear, nose and throat conditions

    Everything NICE has said on ear, nose and throat conditions in an interactive flowchart

  5. Tinnitus

    Everything NICE has said on tinnitus in an interactive flowchart.

  6. Drug misuse management in over 16s

    Everything NICE has said on psychosocial interventions and opioid detoxification for drug misuse in an interactive flowchart

  7. Self-harm

    Everything NICE has said on assessing and managing self-harm in an interactive flowchart

  8. Bipolar disorder

    Everything NICE has said on recognising, assessing and managing bipolar disorder in children, young people and adults in an interactive flowchart

  9. Social anxiety disorder

    Everything NICE has said on recognising, assessing and treating social anxiety disorder in children, young people and adults in an interactive flowchart

  10. Varicose veins in the legs

    Everything NICE has said on diagnosing and managing varicose veins in the legs in an interactive flowchart.

  11. Chest pain

    Everything NICE has said on assessing and managing recent suspected cardiac chest pain including acute coronary syndromes and stable angina in an interactive flowchart

  12. Supporting adult carers

    Everything NICE has said on supporting adults carers in an interactive flowchart

  13. Urogenital conditions

    Everything NICE has said on urogenital conditions in an interactive flowchart

  14. Sepsis

    Everything NICE has said on the recognition, diagnosis and early management of sepsis in an interactive flowchart

  15. Impetigo

    Everything NICE has said on the use of antiseptics and antibiotics to manage impetigo in an interactive flowchart

  16. Antimicrobial stewardship

    Everything NICE has said on effective antimicrobial medicine use and preventing the spread of resistant microbes in an interactive flowchart

  17. Depression

    Everything NICE has said on identifying, treating and managing depression in children, young people and adults in an interactive flowchart

  18. Chronic kidney disease

    Everything NICE has said on chronic kidney disease (renal failure) in an interactive flowchart

  19. The percentage of women with epilepsy aged 18 or over and who have not attained the age of 45 who are taking antiepileptic drugs who have a record of being given information and advice about pregnancy or conception or contraception tailored to their pregnancy and contraceptive intentions recorded in the preceding 12 months

    The percentage of women with epilepsy aged 18 or over and who have not attained the age of 45 who are taking antiepileptic drugs who have a record of...

  20. What are the challenges and potential solutions for UK employers and employees in micro-, small- and medium-sized organisations (which may not have easy access to additional services such as employee assistance programmes or occupational health services) in ensuring sickness policy is managed effectively and facilitating return to work?

    Recommendation ID NG146/5 Question What are the challenges and potential solutions for UK employers and employees in micro-, small- and

  21. For children and young people with intractable cancer-related pain and pain associated with specific diseases (such as epidermolysis bullosa), what is the clinical and cost effectiveness of cannabis-based medicinal products as an add-on to standard treatment to improve symptoms compared with treatment with standard care?

    Recommendation ID NG144/2 Question For children and young people with intractable cancer-related pain and pain associated with specific